Warning! GuruFocus detected
4 Medium warning signs
with DNA.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
DNA Group (TR) Ltd
ISIN : IL0011038523
Description
DNA Group (TR) Ltd invests in biomed companies and has also started to engage in profitable real estate in England.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.97 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 29.44 | |||||
| Beneish M-Score | -2.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 23.7 | |||||
| 3-Year EPS without NRI Growth Rate | -53.3 | |||||
| 3-Year Book Growth Rate | 14.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.06 | |||||
| 9-Day RSI | 43.41 | |||||
| 14-Day RSI | 46.16 | |||||
| 3-1 Month Momentum % | 5.79 | |||||
| 6-1 Month Momentum % | 31.41 | |||||
| 12-1 Month Momentum % | 44.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 60.77 | |||||
| Quick Ratio | 60.77 | |||||
| Cash Ratio | 60.67 | |||||
| Days Sales Outstanding | 253.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -7.3 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -493.46 | |||||
| Net Margin % | 7220.92 | |||||
| FCF Margin % | 526.14 | |||||
| ROE % | 23.76 | |||||
| ROA % | 23.3 | |||||
| ROIC % | -5.18 | |||||
| 3-Year ROIIC % | 17.45 | |||||
| ROCE % | -1.61 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 5.79 | |||||
| PE Ratio without NRI | 57.56 | |||||
| Shiller PE Ratio | 3.66 | |||||
| PEG Ratio | 1.07 | |||||
| PS Ratio | 518 | |||||
| PB Ratio | 1.25 | |||||
| Price-to-Tangible-Book | 1.25 | |||||
| Price-to-Free-Cash-Flow | 79.69 | |||||
| Price-to-Operating-Cash-Flow | 79.69 | |||||
| EV-to-EBIT | -39.26 | |||||
| EV-to-EBITDA | -39.26 | |||||
| EV-to-Revenue | 193.74 | |||||
| EV-to-FCF | 40.96 | |||||
| Price-to-Projected-FCF | 1.82 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.07 | |||||
| Price-to-Graham-Number | 1.79 | |||||
| Price-to-Net-Current-Asset-Value | 1.95 | |||||
| Price-to-Net-Cash | 1.95 | |||||
| Earnings Yield (Greenblatt) % | -2.55 | |||||
| FCF Yield % | 1.26 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DNA Group (TR) Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 0.306 | ||
| EPS (TTM) (₪) | 0.179 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.04 | ||
| 3-Year Sortino Ratio | -0.05 | ||
| Volatility % | 50.24 | ||
| 14-Day RSI | 46.16 | ||
| 14-Day ATR (₪) | 0.057798 | ||
| 20-Day SMA (₪) | 1.07925 | ||
| 12-1 Month Momentum % | 44.21 | ||
| 52-Week Range (₪) | 0.59 - 1.189 | ||
| Shares Outstanding (Mil) | 123.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
DNA Group (TR) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DNA Group (TR) Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
DNA Group (TR) Ltd Frequently Asked Questions
What is DNA Group (TR) Ltd(XTAE:DNA)'s stock price today?
The current price of XTAE:DNA is ₪1.04. The 52 week high of XTAE:DNA is ₪1.19 and 52 week low is ₪0.59.
When is next earnings date of DNA Group (TR) Ltd(XTAE:DNA)?
The next earnings date of DNA Group (TR) Ltd(XTAE:DNA) is .
Does DNA Group (TR) Ltd(XTAE:DNA) pay dividends? If so, how much?
DNA Group (TR) Ltd(XTAE:DNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers